Search

Search Results
Results 17781 - 17790 of 19058 for breast cancer
  • Gardasil 9
    Drug - 2 Nov 2025
    Consumer Medicine Information (CMI) about Gardasil 9 intended for persons living in Australia.
  • Bavencio
    Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Bavencio intended for persons living in Australia.
  • Giotrif
    Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Giotrif intended for persons living in Australia.
  • Tafinlar
    Drug - 27 Oct 2025
    Consumer Medicine Information (CMI) about Tafinlar intended for persons living in Australia.
  • Mekinist
    Drug - 27 Oct 2025
    Consumer Medicine Information (CMI) about Mekinist intended for persons living in Australia.
  • Optimizing cytotoxicity assays with incucyte imaging technology
    White Paper - 9 Oct 2025
    Enhance the accuracy and efficiency of your cytotoxicity assays with Incucyte’s real-time imaging platform.
  • Onureg
    Drug - 8 Oct 2025
    Consumer Medicine Information (CMI) about Onureg intended for persons living in Australia.
  • Scheduling combined visits improves wellness care and reduces no shows
    News - 23 Sep 2025
    A recurrent barrier to Medicare annual wellness visits, which provide preventative medicine guidance for older and disabled patients, occurs when patients introduce medical concerns to physicians...
  • DBL Cisplatin Injection
    Drug - 19 Sep 2025
    Consumer Medicine Information (CMI) about DBL Cisplatin Injection intended for persons living in Australia.
  • Abstral sublingual tablets
    Drug - 16 Sep 2025
    Consumer Medicine Information (CMI) about Abstral sublingual tablets intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback